A novel layered activated carbon with rapid ion transport through chemical activation of chestnut inner shell for capacitive deionization

Autor: Deng, Dingfei, Luhasile, Mapesa K., Li, Haonan, Pan, Qianfeng, Zheng, Fenghua, Wang, Yang

Publikováno v: In Desalination 1 June 2022 531

Development of Potent Pf CLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials.

Autor: Mahindra A; School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K., Janha O; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K., Mapesa K; School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K., Sanchez-Azqueta A; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K., Alam MM; Wellcome Centre for Integrative Parasitology and Centre for Translational Pharmacology, Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, U.K., Amambua-Ngwa A; MRC Unit The Gambia at LSHTM, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia., Nwakanma DC; MRC Unit The Gambia at LSHTM, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia., Tobin AB; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K., Jamieson AG; School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2020 Sep 10; Vol. 63 (17), pp. 9300-9315. Date of Electronic Publication: 2020 Aug 11.

Validation of the protein kinase Pf CLK3 as a multistage cross-species malarial drug target.

Autor: Alam MM; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Sanchez-Azqueta A; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, UK., Janha O; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, UK., Flannery EL; Novartis Institute for Biomedical Research, Emeryville, CA 94608, USA., Mahindra A; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK., Mapesa K; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK., Char AB; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Glasgow G12 8QQ, UK., Sriranganadane D; Structural Genomics Consortium, Universidade Estadual de Campinas, Campinas, São Paulo 13083-886, Brazil., Brancucci NMB; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland., Antonova-Koch Y; Skaggs School of Pharmaceutical Sciences, UC Health Sciences Center for Immunology, Infection and Inflammation, University of California, San Diego, School of Medicine, La Jolla, CA 92093, USA., Crouch K; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Simwela NV; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Millar SB; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Akinwale J; Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, UK., Mitcheson D; Department of Molecular Cell Biology, University of Leicester, Leicester LE1 9HN, UK., Solyakov L; Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, UK., Dudek K; Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, UK., Jones C; Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, UK., Zapatero C; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Doerig C; Biomedical Science Cluster, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology, Melbourne, VIC 3000, Australia., Nwakanma DC; MRC Unit the Gambia, Fajara, Banjul, The Gambia., Vázquez MJ; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Colmenarejo G; Biostatistics and Bioinformatics Unit, IMDEA Food Institute, 28049 Madrid, Spain., Lafuente-Monasterio MJ; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Leon ML; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Godoi PHC; Structural Genomics Consortium, Universidade Estadual de Campinas, Campinas, São Paulo 13083-886, Brazil., Elkins JM; Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Waters AP; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Jamieson AG; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK., Álvaro EF; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Ranford-Cartwright LC; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Glasgow G12 8QQ, UK., Marti M; Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow G12 8QQ, UK., Winzeler EA; Skaggs School of Pharmaceutical Sciences, UC Health Sciences Center for Immunology, Infection and Inflammation, University of California, San Diego, School of Medicine, La Jolla, CA 92093, USA., Gamo FJ; Diseases of the Developing World, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain., Tobin AB; Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, UK. andrew.tobin@glasgow.ac.uk.

Publikováno v: Science (New York, N.Y.) [Science] 2019 Aug 30; Vol. 365 (6456).

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.

Autor: Armstrong, Jane F.¹ (AUTHOR), Campo, Brice² (AUTHOR) campob@mmv.org, Alexander, Stephen P. H.³ (AUTHOR), Arendse, Lauren B.⁴ (AUTHOR), Cheng, Xiu⁵ (AUTHOR), Davenport, Anthony P.⁶ (AUTHOR), Faccenda, Elena¹ (AUTHOR), Fidock, David A.^7,8 (AUTHOR), Godinez‐Macias, Karla P.⁹ (AUTHOR), Harding, Simon D.¹ (AUTHOR), Kato, Nobutaka⁵ (AUTHOR), Lee, Marcus C. S.¹⁰ (AUTHOR), Luth, Madeline R.¹¹ (AUTHOR), Mazitschek, Ralph¹² (AUTHOR), Mittal, Nimisha¹³ (AUTHOR), Niles, Jacquin C.¹⁴ (AUTHOR), Okombo, John⁷ (AUTHOR), Ottilie, Sabine¹¹ (AUTHOR), Pasaje, Charisse Flerida A.¹⁴ (AUTHOR), Probst, Alexandra S.¹⁵ (AUTHOR)

Publikováno v: British Journal of Pharmacology. Aug2023, Vol. 180 Issue 15, p1899-1929. 31p. 1 Diagram, 3 Charts.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.